Janssen Pharmaceutical recently announced that the US Food and Drug Administration (FDA) has awarded the company the breakthrough drug qualification (BTD) for prophylactic RSV advanced vaccines. It is used to prevent lowerRead More…
Personalized cancer vaccine! Melanoma treatment vaccine TLPLDC reduces the risk of recurrence by 50%
Recently, Elios Therapeutics released positive top-line data to evaluate the clinical trial of TLPLDC (tumor lysate, particle loading, dendritic cell) vaccine in the treatment of melanoma in phase IIb. 1.Research result ThisRead More…
New Vaccine – Fight Two Fatal Respiratory Diseases
Recently, scientists at the Center for Infectious Diseases Research at the University of Adelaide in Australia have developed a single vaccination method. It can simultaneously fight two of the world’s deadliest respiratoryRead More…
HIV Prophylactic Vaccine! Patients in the “Mosaic Vaccine” Efficacy Verification Study Have Been Enrolled in the Study
Johnson (JNJ) of the United States recently announced that patients who evaluated the IIb phase proof-of-concept efficacy study Imbokodo (HVTN 705/HPX2008) of a prophylactic HIV vaccine have been enrolled. The study isRead More…
Sci Rep：Needleless vaccine will protect children from dangerous viruses
Thousands of people die of hepatitis B every year. Children are especially in danger. Because of the high cost and stable environmental conditions required for vaccine storage, many people in developing countriesRead More…
Sci Adv：Nanovaccine can improve immunity of patients with metabolic disorder
In a recent study, Cornell University researchers developed a new class of biomaterials for an infectious disease, nanovaccines, which can effectively improve the immunity of mice with metabolic disorders associated with intestinalRead More…
Scientists have developed a vaccine to treat Mycobacterium tuberculosis infection
For years, scientists have been trying to come up with a better way to protect people from mycobacterium tuberculosis, a disease caused by Mycobacterium tuberculosis (Mtb) infection. Dr. Jordi Torrelles, a professorRead More…
Synthetic DNA Vaccine and PD-1 checkpoint Inhibitors in the treatment of Metastasis Cancer with good results
The Inovio Pharmaceuticals recently announced that a second patient with human papillomavirus (HPV) head and neck cancer has achieved sustained complete remission in the first phase of the trial after INO-3112 (nowRead More…
Sanofi and Merck’s Hexavalent Combination Vaccine Approved for the Prevention of Multiple Diseases in Pediatrics
Sanofi has announced that the FDA has approved Vaxelis, a full-liquid ready-to-use hexavalent combination vaccine for infants from 6 weeks old to 4 years old (before the 5th birthday). The vaccine isRead More…
Major Breakthrough in HIV Vaccine Research
In a recent study published in Science Advances, scientists from the Scripps Research Institute overcame technical hurdles to develop a new HIV vaccine candidate that stimulates the body to produce a powerfulRead More…